Concepedia

Yanjing V. Liu

YV

Statistics

Publications

5

Citations

146

H-Index

5

Active since

2021

Affiliations

Harvard Stem Cell Institute(Current)

Brigham and Women's Hospital

Harvard University

National University Cancer Institute, Singapore

Broad Institute

Yanjing V. Liu is an author at Harvard Stem Cell Institute specializing in gene expression, medicine, and hypomethylating agent therapy.

Publications per year

2021–2024

5

Publications

5

Demethylation and Up-Regulation of an Oncogene after Hypomethylating Therapy

Yao‐Chung Liu, Junsu Kwon, Emiliano Fabiani et al. · New England Journal of Medicine · 2022 · 62 citations · Full text

Medicine, Molecular Biology, Oncology +17

Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy

Junyu Yang, Chong Gao, Miao Liu et al. · Cancer Research · 2021 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +17

Optimization of Cas12a for multiplexed genome-scale transcriptional activation

Audrey L. Griffith, Fengyi Zheng, Abby V. McGee et al. · Cell Genomics · 2023 · 26 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Pseudogene-mediated DNA demethylation leads to oncogene activation

Junsu Kwon, Yanjing V. Liu, Chong Gao et al. · Science Advances · 2021 · 22 citations · Full text

Medicine, Cancer Biology, Molecular Biology +16

Modular vector assembly enables rapid assessment of emerging CRISPR technologies

Abby V. McGee, Yanjing V. Liu, Audrey L. Griffith et al. · Cell Genomics · 2024 · 10 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +16

1–5 of 5